Celularity (CELUW) Liabilities and Shareholders Equity (2018 - 2025)

Celularity (CELUW) has 8 years of Liabilities and Shareholders Equity data on file, last reported at $107.3 million in Q4 2025.

• Liabilities and Shareholders Equity for Q4 2025 came in at $107.3 million, down 19.11% year-over-year; the trailing twelve-month figure through Dec 2025 was $470.7 million (down 12.96% YoY), and the FY2025 annual result was $107.3 million, down 19.11% from the prior year.
• Liabilities and Shareholders Equity declined to $107.3 million in Q4 2025 per CELUW's latest filing, from $114.2 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $448.3 million in Q3 2021 and troughed at $107.3 million in Q4 2025.
• A 5-year average of $245.3 million and a median of $150.5 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2022 and 2023: Liabilities and Shareholders Equity soared 234.33% in 2022, then sank 64.12% in 2023.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $414.1 million in 2021, then slipped by 3.15% to $401.1 million in 2022, then slumped by 64.12% to $143.9 million in 2023, then dropped by 7.79% to $132.7 million in 2024, then slipped by 19.11% to $107.3 million in 2025.
• Business Quant data shows CELUW's Liabilities and Shareholders Equity at $107.3 million in Q4 2025, $114.2 million in Q3 2025, and $120.3 million in Q2 2025.